These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7027976)

  • 1. [HBsAg frequency in asymptomatic heroin users living in Milan (author's transl)].
    Natangelo R; Monarca A; Bastia A; Adelasco L; Croce G
    Ann Sclavo; 1980; 22(6):964-71. PubMed ID: 7027976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis associated with drug abuse: significance of hepatitis B virus.
    Miller DJ; Kleber H; Bloomer JR
    Yale J Biol Med; 1979; 52(1):135-40. PubMed ID: 452620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HBsAg carriers in Bratislava and its surroundings and detection by reverse passive haemagglutination (author's transl)].
    Nováková J; Hrubisko M; Pokorná G
    Cas Lek Cesk; 1980 Sep; 119(36-37):973-5. PubMed ID: 7438170
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalences of hepatitis B surface antigen carriers and liver damages in the general population of Hisayama, Japan.
    Kajiwara E; Akagi K; Ueda K; Murai K; Hasuo Y; Kiyohara Y; Wada J; Kawano H; Kato I; Fujishima M
    Fukuoka Igaku Zasshi; 1992 Jun; 83(6):257-61. PubMed ID: 1511951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary studies on HBsAg excretion from saliva in healthy carriers and epidemiological pattern of hepatitis B (author's transl)].
    Cao HL; Wang FL; Du XL; Chen SX; Wang Y; Liu CB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):179-82. PubMed ID: 6459179
    [No Abstract]   [Full Text] [Related]  

  • 8. HBsAg amongst unscreened operated patients.
    Ahmad Q; Chowdhury SG; Islam MN; Khan FD; Alam MR; Miah AH
    Bangladesh Med Res Counc Bull; 1991 Jun; 17(1):11-6. PubMed ID: 1953592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of diseases caused by hepatitis B virus on the island of Favignana].
    Gentile G; Gulì V; La Rosa G; La Licata R
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):274-8. PubMed ID: 901639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are there any variations in the rate of detection of HBsAg in blood donors in the course of years? (author's transl)].
    Petz J; Rocková R
    Cas Lek Cesk; 1982 Apr; 121(15):470-2. PubMed ID: 7083293
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the serological manifestation of the hepatitis B-virus-infections in the Republic of Liberia (author's transl)].
    Neppert J; Gerlich W
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):8-16. PubMed ID: 44626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some remarks of HBsAg and anti-HBs distribution in symptom-free carriers.
    Sabău M; Mosley JW; Demeter S
    Arch Roum Pathol Exp Microbiol; 1977; 36(3-4):255-61. PubMed ID: 617040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Findings on the frequency of apparently healthy carriers of HBsAg in the population of Fermano].
    Natale GM
    Minerva Med; 1978 Jun; 69(30):2069-71. PubMed ID: 683569
    [No Abstract]   [Full Text] [Related]  

  • 14. HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks.
    Giusti G; Galanti B; Gaeta GB; Piccinino F; Ruggiero G
    Hepatogastroenterology; 1981 Apr; 28(2):96-8. PubMed ID: 7216155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HBV serologic markers in the chronic alcoholism (author's transl)].
    Todeschini G; Frandi G; Vicari O; Bontempelli M; Cavagnera A
    Quad Sclavo Diagn; 1981 Jun; 17(2):123-9. PubMed ID: 7267976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
    Ogutu EO; Amayo EO; Okoth F; Lule GN
    East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The epidemiologic and public aspects of HBsAg carriers (author's transl)A1].
    Eynat R
    Harefuah; 1977 Nov; 93(10):298-301. PubMed ID: 604207
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence of hepatitis D virus infection in chronic hepatitis B virus carriers].
    Hacibektaşoğlu A; Barut A; Inal A
    Mikrobiyol Bul; 1992 Jul; 26(3):224-32. PubMed ID: 1528142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological study of healthy carriers of Australia antigen. Analysis of contagiousness, and mechanism of spread of the infection (author's transl)].
    Simó Falcó MD; Lissen Otero E; Caraballo Guijarro R; Sánchez Quijano A; García de Pesquera F; Castro Artigas R; Leal Noval M; Andreu Kern F
    Med Clin (Barc); 1981 Feb; 76(4):161-3. PubMed ID: 7206881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood donors with positive HBsAg in Asturias: its current prevalence and significance].
    Suárez A; Riestra S; Navascués CA; Sotorrío NG; Rodríguez M; Tévar F; Pérez R; Sala P; Rodrigo L
    Med Clin (Barc); 1994 Mar; 102(9):329-32. PubMed ID: 8164459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.